KENNETH I MOCH
CIK 1070009 · President and CEO · last filed 2024-02-02
KENNETH I MOCH is a President and CEO who has filed 31 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for GMDA, was dated Feb 2, 2024. Across all open-market trades the lifetime net is −$753.6K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
31
-$753.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd. (GMDA) Delisted | Director | 232,300 | $0.03 | $7.6K | $0 | 4 | 2024-02-02 |
| Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Director | 47,824 | $1.30 | $62.2K | -$80 | 21 | 2023-10-11 |
| CHIMERIX INC (CMRX) Delisted | President and CEO | 1,313 | $8.54 | $11.2K | -$753.5K | 5 | 2014-03-17 |
| EMIS | Director | — | $10.15 | — | $0 | 1 | 2009-05-19 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-02 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +200,000 | $0 | EDGAR |
| 2023-10-20 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +28,300 | $0 | EDGAR |
| 2023-10-11 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | −75,778 | $0 | EDGAR |
| 2023-06-15 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | +47,709 | -$40 | EDGAR |
| 2023-02-10 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +28,300 | $0 | EDGAR |
| 2022-11-22 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2022-06-16 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | +23,069 | -$40 | EDGAR |
| 2021-08-05 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2020-06-11 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-02 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |